Literature DB >> 12044196

A national 5-year follow-up of treatment outcomes for cocaine dependence.

D Dwayne Simpson1, George W Joe, Kirk M Broome.   

Abstract

BACKGROUND: Long-term (5-year) outcomes of community treatment for cocaine dependence were examined in relation to problem severity at treatment entry and treatment exposure throughout the follow-up period.
METHODS: Interviews were conducted at 1 and 5 years after treatment for 708 subjects (from 45 programs in 8 cities) who met DSM-III-R criteria for cocaine dependence when admitted to treatment in 1991-1993. Primary outcome measures included cocaine use and arrests. Self-reported cocaine use showed high overall agreement with urine (79% agreement) and hair (80% agreement) toxicology analyses.
RESULTS: Weekly cocaine use was reported by 25% of the sample at 5 years, slightly higher than the 21% at 1 year. Similarly, 26% had cocaine detected in urine specimens at follow-up and 18% reported having been arrested. Poorer long-term outcomes were related to higher problem severity at treatment admission and low treatment exposure.
CONCLUSIONS: The large decreases in cocaine use 1 year after treatment discharge were sustained during the 5-year follow-up. Severity of drug and psychosocial problems at intake was predictive of long-term outcomes and outcomes improved in direct relation to level of treatment exposure.

Entities:  

Mesh:

Year:  2002        PMID: 12044196     DOI: 10.1001/archpsyc.59.6.538

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  65 in total

Review 1.  Psychosocial treatments for cocaine dependence.

Authors:  Grace O'Leary Hennessy; Victoria De Menil; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

2.  A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers.

Authors:  Christy K Scott
Journal:  Drug Alcohol Depend       Date:  2004-04-09       Impact factor: 4.492

3.  Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.

Authors:  Richard A Rawson; Joy Chudzynski; Larissa Mooney; Rachel Gonzales; Alfonso Ang; Daniel Dickerson; Jose Penate; Bilal A Salem; Brett Dolezal; Christopher B Cooper
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

4.  Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Authors:  Mary-Lynn Brecht; Diane Herbeck
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

5.  The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Authors:  David A Nielsen; Sara C Hamon; Thomas R Kosten
Journal:  Psychiatr Genet       Date:  2013-12       Impact factor: 2.458

6.  An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.

Authors:  Michael Dennis; Christy K Scott; Rod Funk
Journal:  Eval Program Plann       Date:  2003-08

7.  Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.

Authors:  Michael J Mancino; Janette McGaugh; Mohit P Chopra; Joseph B Guise; Christopher Cargile; D Keith Williams; Jeff Thostenson; Thomas R Kosten; Nichole Sanders; Alison Oliveto
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

8.  Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT.

Authors:  Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Kathryn F Nuro; Melissa A Gordon; Galina A Portnoy; Bruce J Rounsaville
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

9.  Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse.

Authors:  Alexandre B Laudet; Jeffrey B Becker; William L White
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

10.  DBH gene as predictor of response in a cocaine vaccine clinical trial.

Authors:  Thomas R Kosten; Coreen B Domingo; Sara C Hamon; David A Nielsen
Journal:  Neurosci Lett       Date:  2013-02-28       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.